NIH-funded research Sbir 2 grant

Injectable gel for long-lasting pain relief after surgery

Official title: Extended-release injectable gel for multi-day treatment of postoperative pain

Funded at Sonoran Biosciences, INC. · NIH-11066703 · Data updated 2026-11-12

This study is testing a new injectable gel that helps relieve pain after surgery without using opioids, making recovery safer and more comfortable for patients dealing with moderate-to-severe pain.

More Postoperative Pain research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionSonoran Biosciences, INC.
NIH-funded
Lab location1 site (Tempe, United States)
Project startSeptember 6, 2022
Project endDecember 31, 2026
Funding year2025
Award (this year)$1,479,276
NIH project number2R44GM145020-02
Project IDNIH-11066703 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing surgical procedures who are expected to experience moderate-to-severe postoperative pain lasting more than three days.

Less likely to help

Patients who do not undergo surgical procedures or those with mild pain that does not require extended pain management may not benefit from this research.

What this research studies

This research focuses on developing an injectable gel that can provide effective pain relief for patients recovering from surgery without the need for opioids. The gel, which contains bupivacaine, is designed to release medication over an extended period, specifically targeting the management of moderate-to-severe postoperative pain that lasts longer than 24 hours. By using this innovative approach, the research aims to reduce the risks associated with opioid use, such as addiction and adverse events, while improving the overall recovery experience for patients. The methodology involves ensuring that the gel can deliver effective drug concentrations directly to the surgical site, enhancing pain management outcomes.

Why it matters

Potential benefit: If successful, this research could significantly reduce the reliance on opioids for postoperative pain management, leading to safer recovery experiences for patients.

How similar studies have gone: Other research has shown promise in using extended-release formulations for pain management, but this specific approach with injectable gel technology is relatively novel.

Where this research is happening

  • Sonoran Biosciences, INC.
    Tempe, United States
    Active

Researchers

  • Principal investigator: Overstreet, Derek James — Sonoran Biosciences, INC.
  • Study coordinator: Overstreet, Derek James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.